See more : QEM Limited (QEM.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Privi Speciality Chemicals Limited (PRIVISCL.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Privi Speciality Chemicals Limited, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Haymaker Acquisition Corp. III (HYACW) Income Statement Analysis – Financial Results
- Hollyland (China) Electronics Technology Corporation Limited (002729.SZ) Income Statement Analysis – Financial Results
- Nanfang Ventilator Co., Ltd. (300004.SZ) Income Statement Analysis – Financial Results
- China Television Media, Ltd. (600088.SS) Income Statement Analysis – Financial Results
- Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM) Income Statement Analysis – Financial Results
Privi Speciality Chemicals Limited (PRIVISCL.BO)
About Privi Speciality Chemicals Limited
Privi Speciality Chemicals Limited operates as a manufacturer, supplier, and exporter of aroma and fragrance chemicals in India, North America, Asia, Middle East, Middle East, Africa, Europe, and the United Kingdom. The company offers amber fleur, acetates, dihydromyrcenol, ionones, nitriles, sandal wood derivatives, and specialty chemicals, as well as bulk aroma chemicals. It provides aroma chemicals, including alpha damascone, alpha ionone, alpha terpenyl acetate, amber fleur, amber gamma, beta iso damascol, BI perfumery grade, BI technical grade, carene-60 & Carene-90, cedar ketol, citronellal, citronellyl acetate, citronellyl nitrile, dipentene, double distilled turpentine oil, dihydro myrcenol, dihydromyrcene, gamma methyl ionone, gamma terpenyl acetate, geraniol, geranyl acetate, Indian sandal core, ionone, iso boronyl acetate, l-limonene, methyl ionone, nerol, neryl acetate, nimberol, OTBCHA, pine oil, prionyl, PTBCHA, rose oxide, terpeniol alpha, terpeniol gamma, terpeniol BP grade, terpinolene, and sandal fleur, as well as sandal touch, tetrahydroflorol, tetrahydrogeraniol, tetrahydrogeranyl acetate, tetrahydromyrcenol, timber forte, and timber touch. The company was formerly known as Fairchem Speciality Limited and changed its name to Privi Speciality Chemicals Limited in October 2020. The company was incorporated in 1985 and is based in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 17.52B | 16.05B | 14.02B | 12.68B | 13.04B | 13.25B | 10.13B | 5.90B | 1.50B | 1.50B | 1.51B | 1.22B | 964.96M | 573.60M | 383.91M | 340.31M | 311.71M |
| Cost of Revenue | 10.56B | 9.88B | 8.48B | 7.69B | 8.18B | 8.40B | 6.73B | 3.98B | 1.02B | 1.01B | 961.23M | 892.78M | 687.71M | 364.87M | 232.36M | 194.74M | 164.89M |
| Gross Profit | 6.96B | 6.18B | 5.55B | 4.99B | 4.86B | 4.85B | 3.40B | 1.92B | 480.60M | 489.79M | 544.07M | 328.79M | 277.25M | 208.73M | 151.55M | 145.58M | 146.82M |
| Gross Profit Ratio | 39.74% | 38.47% | 39.56% | 39.34% | 37.25% | 36.62% | 33.58% | 32.53% | 32.08% | 32.73% | 36.14% | 26.92% | 28.73% | 36.39% | 39.47% | 42.78% | 47.10% |
| Research & Development | 20.25M | 53.71M | 65.17M | 61.54M | 68.28M | 66.09M | 60.40M | 39.81M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 240.02M | 296.59M | 247.56M | 279.76M | 330.85M | 192.84M | 88.77M | 75.49M | 13.74M | 6.53M | 5.96M | 5.23M | 4.00M | 3.38M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 724.99M | 891.06M | 798.16M | 508.50M | 395.86M | 324.76M | 318.77M | 130.36M | 17.54M | 16.09M | 12.52M | 9.73M | 8.50M | 7.94M | 0.00 | 0.00 | 0.00 |
| SG&A | 965.01M | 1.19B | 1.05B | 788.26M | 726.71M | 517.60M | 407.53M | 205.85M | 31.28M | 22.62M | 18.47M | 14.96M | 12.51M | 11.32M | 0.00 | 0.00 | 0.00 |
| Other Expenses | 263.00M | 22.63M | 25.87M | 7.22M | 55.42M | 9.14M | 6.44M | 11.17M | 5.61M | 337.24K | 3.63M | 45.45K | 111.85K | 1.39M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.29B | 5.38B | 4.34B | 3.59B | 3.21B | 3.12B | 2.53B | 1.47B | 277.67M | 261.62M | 237.63M | 177.27M | 149.20M | 121.30M | 141.95M | 147.65M | 131.06M |
| Cost & Expenses | 15.45B | 15.26B | 12.81B | 11.28B | 11.40B | 11.52B | 9.25B | 5.45B | 1.30B | 1.27B | 1.20B | 1.07B | 836.91M | 486.17M | 374.32M | 342.39M | 295.95M |
| Interest Income | 3.22M | 2.82M | 2.99M | 4.81M | 7.70M | 7.86M | 12.74M | 16.89M | 73.84K | 182.06K | 337.26K | 216.42K | 209.81K | 288.97K | 297.52K | 489.33K | 601.54K |
| Interest Expense | 1.01B | 678.13M | 241.13M | 214.10M | 341.09M | 290.15M | 239.40M | 169.76M | 37.94M | 27.39M | 26.56M | 24.79M | 21.23M | 13.76M | 16.50M | 18.73M | 15.09M |
| Depreciation & Amortization | 1.23B | 1.08B | 746.62M | 710.00M | 567.72M | 468.54M | 433.09M | 268.25M | 29.94M | 22.17M | 26.43M | 22.65M | 19.76M | 17.31M | 16.91M | 16.54M | 16.16M |
| EBITDA | 3.51B | 2.09B | 2.33B | 2.52B | 2.81B | 2.26B | 1.46B | 820.50M | 234.69M | 256.68M | 336.93M | 173.74M | 148.98M | 110.18M | 26.19M | 14.46M | 33.60M |
| EBITDA Ratio | 20.05% | 12.91% | 16.17% | 18.02% | 18.70% | 17.05% | 14.46% | 13.39% | 16.01% | 17.06% | 22.39% | 14.45% | 15.49% | 18.37% | 6.96% | 4.25% | 9.96% |
| Operating Income | 2.08B | 831.51M | 1.23B | 1.34B | 1.46B | 1.61B | 780.11M | 391.62M | 165.54M | 205.50M | 283.94M | 126.30M | 107.98M | 79.10M | -6.84M | -20.32M | 2.58M |
| Operating Income Ratio | 11.86% | 5.18% | 8.77% | 10.59% | 11.23% | 12.15% | 7.70% | 6.64% | 11.05% | 13.73% | 18.86% | 10.34% | 11.19% | 13.79% | -1.78% | -5.97% | 0.83% |
| Total Other Income/Expenses | -777.84M | -521.08M | 98.30M | 182.04M | 285.05M | -219.65M | -81.86M | -97.92M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -7.61M | -15.17M | -19.97M | -12.54M |
| Income Before Tax | 1.30B | 310.43M | 1.33B | 1.58B | 1.93B | 1.52B | 789.56M | 355.59M | 165.54M | 205.50M | 283.94M | 126.30M | 107.98M | 79.10M | -6.84M | -20.32M | 2.58M |
| Income Before Tax Ratio | 7.42% | 1.93% | 9.47% | 12.48% | 14.77% | 11.43% | 7.80% | 6.02% | 11.05% | 13.73% | 18.86% | 10.34% | 11.19% | 13.79% | -1.78% | -5.97% | 0.83% |
| Income Tax Expense | 344.80M | 97.65M | 353.74M | 413.22M | 466.04M | 573.16M | 256.04M | 84.35M | 59.54M | 68.65M | 97.12M | 42.43M | 34.23M | 28.44M | -1.28M | -5.82M | -5.64M |
| Net Income | 949.07M | 222.15M | 973.80M | 1.17B | 1.46B | 942.44M | 533.52M | 271.24M | 105.99M | 136.86M | 186.82M | 83.86M | 73.75M | 50.66M | -5.56M | -14.50M | 8.22M |
| Net Income Ratio | 5.42% | 1.38% | 6.94% | 9.22% | 11.20% | 7.11% | 5.27% | 4.60% | 7.08% | 9.15% | 12.41% | 6.87% | 7.64% | 8.83% | -1.45% | -4.26% | 2.64% |
| EPS | 24.30 | 5.69 | 24.93 | 29.93 | 37.38 | 24.13 | 13.66 | 8.86 | 7.68 | 9.92 | 13.54 | 5.53 | 5.35 | 3.67 | -0.40 | -1.05 | 0.60 |
| EPS Diluted | 24.30 | 5.69 | 24.93 | 29.93 | 37.38 | 24.13 | 13.66 | 8.86 | 7.68 | 9.92 | 13.54 | 5.53 | 5.35 | 3.67 | -0.40 | -1.05 | 0.60 |
| Weighted Avg Shares Out | 39.06M | 39.06M | 39.06M | 39.06M | 39.06M | 39.06M | 39.06M | 30.62M | 13.79M | 13.79M | 12.54M | 13.79M | 13.79M | 13.79M | 13.79M | 13.79M | 13.79M |
| Weighted Avg Shares Out (Dil) | 39.06M | 39.06M | 39.06M | 39.06M | 39.06M | 39.06M | 39.06M | 30.62M | 13.79M | 13.79M | 12.54M | 13.79M | 13.79M | 13.79M | 13.79M | 13.79M | 13.79M |
Source: https://incomestatements.info
Category: Stock Reports